BioCurate Pty Ltd

Join us for the "Considerations when investing in early-stage university spin-outs" panel today at 2:20 PM - 3:05 PM! 🕑 Dr Kathy Nielsen, CEO at BioCurate Pty Ltd, will be sharing her expertise alongside: 🔬 Dr Michael Bettess (Brandon Capital)  🧪 Dr Aoife Cullen (Monash Innovation)  🔬 Dr Amir Zalcenstein (SYNthesis BioVentures) 💼 with Dr John Kurek (Uniseed) as Chair This power-packed panel will explore the ins and outs of investing in university spin-outs, covering everything from pipeline potential to managing expectations. 🎓💡 Don't miss this chance to gain valuable insights into early-stage life science investments! 💪🏼 #AusBio2024 #BioCurate #InvestmentInsights Victorian Government

AusBiotech 2024 is well underway! Visit the BioCurate team at the Victorian Government Pavilion booth #4. We look forward to forming new connections with the sector and deepening our established partnerships. To keep up to date through the conference, follow us on Twitter @BioCurate. #AusBio2024 Tifelle Reisinger Kathy Nielsen Frederico Calhabeu Francis Kirby

AusBiotech 2024 has officially kicked off today! Don't miss the opportunity to visit BioCurate at the Victorian Government booth #4. 🤝 Our team is also available to connect through the AusPartnering program. Dr Kathy Nielsen, CEO Dr Francis Kirby, Partnerships and Strategy Manager Dr Frederico Calhabeu, Director of Cell and Gene Therapies Dr Tifelle Reisinger, Associate Director, Medicinal Chemistry Discovery and Stakeholder Management 📢 Dr Kathy Nielsen will be participating in the panel "Considerations when investing in early-stage university spin-outs" on Thursday, October 31, from 2:20 PM - 3:05 PM. Reach out to connect and share insights around the future possibilities of our industry! #AusBio2024 #Biotechnology #LifeSciences #Innovation #Melbourne 

Thrilled to announce our small molecule drug discovery arm #QEDDI is partnering with BioCurate Pty Ltd to develop a potential new treatment for pain and a safer alternative to opioids. Great to have this exciting partnership launched during AusBiotech #AusBiotech2024! 💊💊💊 #QEDDI #UniQuest #drugdiscovery #smallmolecules #biomedicalresearch #collaboration #drugtranslation #neuropathicpain

BioCurate is excited to announce a new partnership with UniQuest’s small molecule drug discovery and development engine, the Queensland Emory Drug Discovery Initiative (QEDDI), with the aim to develop a new effective treatment for neuropathic pain with potential to become a safe alternative to opioids. “There is so much need for new treatments and pooling resources and expertise through early-stage partnerships such as this one between BioCurate and QEDDI is vital to success.” - Dr Kathy Nielsen, CEO of BioCurate Pty Ltd. Read the media release via: https://lnkd.in/gMcez4iN #QEDDI #UniQuest #drugdiscovery #smallmolecules, #biomedicalresearch, #collaboration, #drugtranslation

Connecting capital with health innovation at #AusBioInvest2024! BioCurate CEO Dr Kathy Nielsen joins other industry leaders today for ground-breaking discussions on health innovation and investment opportunities in Australia's thriving biotech sector. Thanks to Host State Partner Victorian Government for supporting this premier event! #AusBio2024

Dr Kathy Nielsen will join other industry leaders at #AusBioInvest2024 for groundbreaking discussions on health innovation and investment opportunities in Australia's thriving biotech sector. 📅 Tuesday, 29th October 2024  📍Park Hyatt Hotel in Melbourne for AusBioInvest 2024. Connecting capital with health innovation at #AusBioInvest2024!  🧬🔬 #BioTech #AusBio2024 Victorian Government

Less than a month until the #I2T2024symposium, proudly sponsored by Bio21 Institute and Scientifix Pty Ltd Final program for the symposium includes: 🌟 Invited speakers from across the Melbourne biotech sector 🏆Updates from past MTx pitch competition winners 🎙️Expert panel on research commercialisation – sponsored by BioCurate Pty Ltd 📣Do not miss out on available spots and register here: https://lnkd.in/dTwxAj4t

Excited to announce that BioCurate will be at AusBiotech 2024, Australia's premier life sciences conference. 📅 30 October - 1 November 2024 📍 Melbourne Convention & Exhibition Centre 🏢 Visit us at the Victorian Government booth 4. Our team is looking forward to connecting with industry leaders, researchers, and innovators in the development of new therapeutics. BioCurate representatives attending and available for AusPartnering meetings: Dr Kathy Nielsen, CEO Dr Francis Kirby, Partnerships and Strategy Manager Dr Frederico Calhabeu, Director of Cell and Gene Therapies Dr Tifelle Reisinger, Associate Director, Medicinal Chemistry Discovery and Stakeholder Management Dr Kathy Nielsen will be sharing insights: Panel: "Considerations when investing in early-stage university spin-outs" 📅 Thursday, 31 October 2024 ⏰ 2:20 PM - 3:05 PM Attending: AusBiotech Invest 📅 Tuesday, 29th October 2024 Join us as we explore the future of life sciences and showcase Australia's innovative potential on the world stage. #AusBio2024 #Biotechnology #LifeSciences #Innovation #Melbourne

We're proud to support a groundbreaking project at Monash University through our Proof of Concept (POC) Fund. Dr Chengxue Helena Qin 秦承雪 and her multidisciplinary team are developing a novel treatment for pulmonary artery hypertension, a devastating disease that primarily affects women. 🔬 The project aims to create a disease-modifying therapy targeting a key G-protein coupled receptor involved in lung vessel inflammation and remodelling. 🤝 BioCurate's involvement has been crucial, providing: - Critical funding to bridge gaps - Industry insights to enhance commercial viability - Fresh perspectives on scientific and commercial processes “We were very impressed with their thinking about both the scientific and commercial aspects of the project,” Dr Qin said. “Some of those discussions were challenging – they really encouraged us to push our boundaries and think about whether we were taking the right approach.” This collaboration showcases the power of academia-industry partnerships in advancing life-changing therapies. We're excited to see how this project develops and its potential impact on #PAH patients' lives. Read more about Dr Qin’s work and experience with the POC fund here: https://lnkd.in/gVy4a4Vy Monash Institute of Pharmaceutical Sciences Rebecca Ritchie Katie Leach Paul Stupple Lauren May Kieran Stockton, Julian Vultaggio #MedicalResearch #DrugDiscovery #Innovation #BioCurate